| Product Code: ETC7744746 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of PD-1 and PD-L1 inhibitors in Japan saw a consistent decline from 2020 to 2024, with a CAGR of -3.67%. Despite this downward trend, the top exporting countries to Japan in 2024 were the USA, Germany, Switzerland, Ireland, and Sweden. The Herfindahl-Hirschman Index (HHI) revealed a low concentration in 2023, which further decreased to very low concentration in 2024. The negative growth rate of -3.17% from 2023 to 2024 suggests a challenging market environment for PD-1 and PD-L1 inhibitors in Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan PD-1 and PD-L1 Inhibitors Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Japan PD-1 and PD-L1 Inhibitors Market - Industry Life Cycle |
3.4 Japan PD-1 and PD-L1 Inhibitors Market - Porter's Five Forces |
3.5 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Inhibitors, 2021 & 2031F |
3.6 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan PD-1 and PD-L1 Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Japan |
4.2.2 Rising investments in healthcare and research development |
4.2.3 Growing adoption of immunotherapy treatments in Japan |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new drugs |
4.3.2 High costs associated with PD-1 and PD-L1 inhibitors |
4.3.3 Limited awareness among healthcare professionals and patients about these treatments |
5 Japan PD-1 and PD-L1 Inhibitors Market Trends |
6 Japan PD-1 and PD-L1 Inhibitors Market, By Types |
6.1 Japan PD-1 and PD-L1 Inhibitors Market, By Inhibitors |
6.1.1 Overview and Analysis |
6.1.2 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Inhibitors, 2021- 2031F |
6.1.3 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By PD-1 Inhibitors, 2021- 2031F |
6.1.4 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By PD-L1 Inhibitors, 2021- 2031F |
6.2 Japan PD-1 and PD-L1 Inhibitors Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Hodgkin Lymphoma, 2021- 2031F |
6.2.3 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Kidney Cancer, 2021- 2031F |
6.2.4 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.2.5 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Non-small Cell Lung Cancer, 2021- 2031F |
6.2.6 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.3 Japan PD-1 and PD-L1 Inhibitors Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Japan PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Japan PD-1 and PD-L1 Inhibitors Market Import-Export Trade Statistics |
7.1 Japan PD-1 and PD-L1 Inhibitors Market Export to Major Countries |
7.2 Japan PD-1 and PD-L1 Inhibitors Market Imports from Major Countries |
8 Japan PD-1 and PD-L1 Inhibitors Market Key Performance Indicators |
8.1 Number of clinical trials conducted for PD-1 and PD-L1 inhibitors in Japan |
8.2 Patient survival rates and quality of life improvements with the use of these inhibitors |
8.3 Adoption rate of PD-1 and PD-L1 inhibitors in different types of cancer treatments |
9 Japan PD-1 and PD-L1 Inhibitors Market - Opportunity Assessment |
9.1 Japan PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Inhibitors, 2021 & 2031F |
9.2 Japan PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan PD-1 and PD-L1 Inhibitors Market - Competitive Landscape |
10.1 Japan PD-1 and PD-L1 Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Japan PD-1 and PD-L1 Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here